Variant report
Variant | esv1805364 |
---|---|
Chromosome Location | chr6:141051437-141055590 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:141041326..141043698-chr6:141051751..141054060,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1879505 | chr6:141051437-141051438 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs568679444 | chr6:141051475-141051476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1521147 | chr6:141051480-141051481 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs557689742 | chr6:141051486-141051487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs575675472 | chr6:141051505-141051506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561053011 | chr6:141051558-141051559 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117888126 | chr6:141051578-141051579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558159626 | chr6:141051592-141051593 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574392214 | chr6:141051597-141051598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1521146 | chr6:141051626-141051627 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs540759655 | chr6:141051645-141051646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184120089 | chr6:141051651-141051652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574293346 | chr6:141051654-141051655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376129591 | chr6:141051683-141051684 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188671434 | chr6:141051719-141051720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12530226 | chr6:141051731-141051732 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530399613 | chr6:141051743-141051744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73569704 | chr6:141051751-141051752 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs564144556 | chr6:141051752-141051753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs193234145 | chr6:141051804-141051805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1521145 | chr6:141051823-141051824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs147168322 | chr6:141051826-141051827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529520548 | chr6:141051828-141051829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138440501 | chr6:141051865-141051866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569548939 | chr6:141051935-141051936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143748353 | chr6:141051990-141051991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77652402 | chr6:141052003-141052004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557856623 | chr6:141052052-141052053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566902794 | chr6:141052072-141052073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182722094 | chr6:141052079-141052080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370602606 | chr6:141052101-141052102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs150683887 | chr6:141052158-141052159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371576528 | chr6:141052198-141052199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374054901 | chr6:141052214-141052215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574255346 | chr6:141052264-141052265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541647503 | chr6:141052344-141052345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548888918 | chr6:141052352-141052353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368115739 | chr6:141052380-141052381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556768291 | chr6:141052381-141052382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575177389 | chr6:141052427-141052428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546120709 | chr6:141052440-141052441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7740416 | chr6:141052462-141052463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370099443 | chr6:141052475-141052476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528092509 | chr6:141052487-141052488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539909694 | chr6:141052490-141052491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186777799 | chr6:141052532-141052533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191782119 | chr6:141052542-141052543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184005378 | chr6:141052580-141052581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149864400 | chr6:141052650-141052651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2460956 | chr6:141052659-141052660 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:141047600-141054800 | Weak transcription | NHDF-Ad | bronchial |
2 | chr6:141049800-141051800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr6:141051000-141052600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
4 | chr6:141051200-141051800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr6:141051600-141051800 | Enhancers | Psoas Muscle | Psoas |
6 | chr6:141051800-141053000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr6:141052400-141053800 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr6:141052600-141052800 | Enhancers | Osteobl | bone |
9 | chr6:141052600-141053200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr6:141052600-141053400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr6:141052800-141053200 | Enhancers | Rectal Smooth Muscle | rectum |
12 | chr6:141053000-141053600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr6:141053200-141057600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
14 | chr6:141053400-141057200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr6:141053800-141057400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
16 | chr6:141054600-141055000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr6:141054800-141055200 | Enhancers | NHDF-Ad | bronchial |
18 | chr6:141054800-141055200 | Enhancers | Osteobl | bone |
19 | chr6:141055000-141057200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr6:141055200-141057200 | Weak transcription | Osteobl | bone |
21 | chr6:141055200-141057600 | Weak transcription | NHDF-Ad | bronchial |